Truist Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$229K Buy
2022
Q4
Sell
2022
Q3
$392K Buy
2022
Q2
$200K Sell
2022
Q1
$232K Sell
2021
Q4
$312K Sell
2021
Q3
$906K Buy
2021
Q2
$1.08M Sell
2021
Q1
$872K Buy
2020
Q4
$1.04M Buy
2020
Q3
$321K Sell
2020
Q2
$329K Sell
2020
Q1
$236K Buy